(Q33804506)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21269503%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21269503%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21269503%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

3

Dick Menzies

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21269503%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

5

Kevin Schwartzman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21269503%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Olivia Oxlade

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21269503%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Anne Aspler

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21269503%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

English

0 references

publication date

26 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21269503%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21269503%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21269503%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21269503%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1186/1471-2458-11-55

20 January 2020

exact match

0 references

cites work

Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

A New Vaccine for Tuberculosis: The Challenges of Development and Deployment

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

TB vaccines: current status and future perspectives

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Biomarkers for tuberculosis disease activity, cure, and relapse

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Modeling the effects of strain diversity and mechanisms of strain competition on the potential performance of new tuberculosis vaccines

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Cost of tuberculosis diagnosis and treatment from the patient perspective in Lusaka, Zambia.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Prevalence of tuberculous infection and incidence of tuberculosis: a re-assessment of the Styblo rule.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Multidrug-resistant tuberculosis management in resource-limited settings

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Impact of DOTS expansion on tuberculosis related outcomes and costs in Haiti

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Global incidence of multidrug-resistant tuberculosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Progress in tuberculosis vaccine development

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Advances in tuberculosis vaccine strategies

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Potential public health impact of new tuberculosis vaccines

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Scale up: meeting targets in global tuberculosis control

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Integration of tuberculosis screening at an HIV voluntary counselling and testing centre in Haiti

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Boosting vaccine for tuberculosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Preventing tuberculosis with bacillus Calmette-Guérin vaccine: a meta-analysis of the literature

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Patient and health care system delays in the diagnosis and treatment of tuberculosis.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Cost-effectiveness of the polymerase chain reaction versus smear examination for the diagnosis of tuberculosis in Kenya: a theoretical model.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Risk factors for relapse in human immunodeficiency virus type 1 infected adults with pulmonary tuberculosis.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Tuberculosis and human immunodeficiency virus infection in west Burkina Faso: clinical presentation and clinical evolution

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Issues in the management of contacts of patients with active pulmonary tuberculosis.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Relapse of tuberculosis after treatment in human immunodeficiency virus-infected patients

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Management of health care workers after inadvertent exposure to tuberculosis: a guide for the use of preventive therapy

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Variation in protection by BCG: implications of and for heterologous immunity

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Tuberculosis morbidity in the U.S. Navy: its distribution and decline

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Tuberculosis in a Cohort of Southeast Asian Refugees: A Five-Year Surveillance Study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Contacts of cases of active pulmonary tuberculosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Results in pulmonary tuberculosis patients under various treatment program conditions

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

The limits to patient compliance with directly observed therapy for tuberculosis: a socio-medical study in Pakistan.

4 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-55

Domestic returns from investment in the control of tuberculosis in other countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-55

Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-55

Modelling the effects of pre-exposure and post-exposure vaccines in tuberculosis control

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-55

The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-55

Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-55

The impact of the HIV epidemic on tuberculosis transmission in Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-55

HIV infection in Haiti: natural history and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-55

Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-55

Movement of tuberculosis patients and the failure to complete antituberculosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-55

Immunological conditions of children with BCG disseminated infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-55

Does one size fit all? Drug resistance and standard treatments: results of six tuberculosis programmes in former Soviet countries.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

DOTS implementation in a middle-income country: development and evaluation of a novel approach.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Gender difference in delays to diagnosis and health care seeking behaviour in a rural area of Nepal

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Delay in tuberculosis case-finding and treatment in Mwanza, Tanzania

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039588

Results at 5 years of a controlled comparison of a 6-month and a standard 18-month regimen of chemotherapy for pulmonary tuberculosis

30 October 2018

1 reference

12 December 2020

Risk factors for developing tuberculosis in HIV-1-infected adults from communities with a low or very high incidence of tuberculosis

1 reference

12 December 2020

Patient and disease characteristics, and outcome of treatment defaulters from the Singapore TB control unit--a one-year retrospective survey

1 reference

12 December 2020

Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection

1 reference

12 December 2020

A controlled clinical trial of 3- and 5-month regimens in the treatment of sputum-positive pulmonary tuberculosis in South India. Tuberculosis Research Centre, Madras, and National Tuberculosis Institute, Bangalore

1 reference

12 December 2020

Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. Second report of the 4th study. East African/British Medical Research Councils Study

1 reference

12 December 2020

Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic Association (third report)

1 reference

12 December 2020

Economic evaluation of vaccination programs: the impact of herd-immunity

1 reference

12 December 2020

Long-term follow-up of a clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council

1 reference

12 December 2020

A prospective study of the risk of tuberculosis among HIV-infected patients

1 reference

12 December 2020

A novel approach to directly observed therapy for tuberculosis in an HIV-endemic area

1 reference

12 December 2020

Revised BCG vaccination guidelines for infants at risk for HIV infection

1 reference

12 December 2020

Controlled clinical trial comparing a 6-month and a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Algerian working group/British Medical Research Council cooperative study

1 reference

12 December 2020

Public health aspects of relapsing tuberculosis

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2458-11-55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21269503%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

20 January 2020

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2458-11-55

9 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21269503%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

PubMed publication ID

21269503

1 reference